Back to School: How biopharma can reboot drug development. Access exclusive analysis here
MicroProbe Corp. withdrew its Affirm VP line of DNA probe-based products from the market to avoid the costs of litigating a patent dispute with Gen-Probe Inc., but said it believes it can
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury